Is Forte Biosciences Inc (FBRX) overvalued? · $360.2M cap
Forte Biosciences Inc (FBRX) is a biotechnology company listed on NASDAQ.
This page asks whether Forte Biosciences Inc (FBRX) looks expensive on cached numbers — not a short thesis.
No cached income statement for FBRX, so there is no earnings base to call rich or cheap.
FBRX currently screens at market cap $360.2M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next FBRX 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the FBRX stock page for the full model, not this heading.
Not investment advice.